News April 23, 2021 OS Therapies Completes $6 Million Series A Funding Round Led by Noble Capital Markets and Tichenor Ventures to Fund OST-HER2 PhIIb Trial and OST-TDC… Super User Love0
News April 23, 2021 The Workshop (May 13 & 14, 2021) The purpose of this event is to bring Technology Transfer leaders, policy makers, thought leaders,… Super User Love0
News April 23, 2021 Cellphire Therapeutics Names Michael Gaffney as Company’s New CEO ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation… Super User Love0
News April 23, 2021 Federal Laboratory Consortium for Technology Transfer Archives · BioBuzz The Montgomery County Economic Development Corporation (MCEDC) and the Federal Laboratory Consortium (FLC) have signed… Super User Love0
News April 23, 2021 TEDCO’s Seed Fund Invests $200K in Maryland Technology Startup, Completing $850K Investment Round | TEDCO COLUMBIA, Md. (April 20, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed… Super User Love0
News April 23, 2021 Largest Venture Capital Investors in Greater D.C. – Washington Business Journal Largest Venture Capital Investors in Greater D.C. - Washington Business Journal Image: https://www.bizjournals.com (more…) Super User Love0
News April 23, 2021 FDA approves GSK’s endometrial cancer therapy – MarketWatch U.S.-listed shares of GlaxoSmithKline GSK, 0.12% were down 1.4% in trading on Thursday after the… Super User Love0
News April 22, 2021 Chinese diagnostics company expands business to Maryland amid pandemic | Maryland Business News Amid the international effects of the COVID-19 pandemic, Maccura Biotechnology, headquartered in the city of… Super User Love0
News April 22, 2021 Bethesda’s Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals · BioBuzz BETHESDA, Md., April 20, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) today… Super User Love0
News April 22, 2021 United Therapeutics submits new drug application to FDA to treat pulmonary arterial hypertension | WRAL TechWire RESEARCH TRIANGLE PARK — United Therapeutics has applied for a priority review voucher and submitted a… Super User Love0